GlucoTrack (GCTK) Osake Kurssi

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 3 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing two products: a non-invasive glucose monitor for use by those with Type II diabetes and prediabetes, and an implantable continuous glucose monitor for those with Type I diabetes and insulin-dependent Type II diabetes. The firm's GlucoTrack is a noninvasive glucose monitoring device designed to help people with diabetes and pre-diabetics obtain glucose level readings without the conventional (invasive) spot finger stick devices. The company is also engaged in developing an implantable continuous glucose monitor for use by Type I diabetes patients as well as insulin-dependent Type II patients. The company develops its own companion applications and a cloud-based solutions to offer an effective platform to provide real time, data driven personalized tools to help a user manage their diabetes.